|
|
||||||||



,§
*
Department of Medicine, Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106;
Case Western Reserve University, Cleveland, OH 44106;
Department of Dermatology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH 44106; and
§
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106
Allograft rejection has been associated with detection of the type
1 lymphokines, IFN-
and IL-2. The role of type 2 cytokines (IL-4 and
IL-5) remains controversial, as is whether alloreactive
CD4+ and CD8+ T cells behave similarly when
exposed to type 2 cytokine-enhancing manipulations. We studied the
characteristics of alloreactive CD4+ and CD8+ T
cells before and after type 2 immune deviation induced by IL-4 plus
anti-IFN-
Ab. Alloreactive T cells from naive mice were low in
frequency, produced only IL-2, and were predominantly CD4+,
while alloreactive T cells from allograft-primed mice were high in
frequency, produced IFN-
, IL-2, and IL-4, and were predominantly
CD8+. Type 2 immune deviation of allospecific
CD4+ T cells resulted in IL-4 and IL-5 production without
IFN-
, consistent with unipolar type 2 immunity. These T cells
mediated delayed-type hypersensitivity, but not cytotoxicity. Under
identical type 2 cytokine-inducing conditions, allospecific
CD8+ T cells were primed to become IL-4, IL-5, and IFN-
producers, and exhibited cytotoxicity, but not classic delayed-type
hypersensitivity. Adoptive transfer of either cell population into SCID
recipients of allogeneic skin resulted in graft rejection, with stable
allospecific type 2 cytokine production in vivo. Adoptive transfer of
the IL-4/IL-5-producing CD4+ T cells, but not the
CD8+ T cells, induced a distinct histopathology
characterized by marked eosinophilic infiltration of the skin. We
conclude that type 2 immune deviation has differential effects on
CD4+ and CD8+ T cells and results in emergence
of alternate effector mechanisms capable of destroying
allografts.
This article has been cited by other articles:
![]() |
V. Pavlov, H. Raedler, S. Yuan, S. Leisman, W.-h. Kwan, P. N. Lalli, M. E. Medof, and P. S. Heeger Donor Deficiency of Decay-Accelerating Factor Accelerates Murine T Cell-Mediated Cardiac Allograft Rejection J. Immunol., October 1, 2008; 181(7): 4580 - 4589. [Abstract] [Full Text] [PDF] |
||||
![]() |
R P Anderson, D A van Heel, J A Tye-Din, M Barnardo, M Salio, D P Jewell, and A V S Hill T cells in peripheral blood after gluten challenge in coeliac disease Gut, September 1, 2005; 54(9): 1217 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Amano, A. Bickerstaff, C. G. Orosz, A. C. Novick, H. Toma, and R. L. Fairchild Absence of Recipient CCR5 Promotes Early and Increased Allospecific Antibody Responses to Cardiac Allografts J. Immunol., May 15, 2005; 174(10): 6499 - 6508. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamada, A. D. Salama, M. Sho, N. Najafian, T. Ito, J. P. Forman, R. Kewalramani, S. Sandner, H. Harada, M. R. Clarkson, et al. CD70 Signaling Is Critical for CD28-Independent CD8+ T Cell-Mediated Alloimmune Responses In Vivo J. Immunol., February 1, 2005; 174(3): 1357 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hargrave, C. Hay, J. Mellon, E. Mayhew, and J. Y. Niederkorn Fate of MHC-Matched Corneal Allografts in Th1-Deficient Hosts Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1188 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, Y. Demir, A. Valujskikh, and P. S. Heeger Antigen Location Contributes to the Pathological Features of a Transplanted Heart Graft Am. J. Pathol., April 1, 2004; 164(4): 1407 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. He, S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R. L. Fairchild, and P. S. Heeger Effects of T Cell Frequency and Graft Size on Transplant Outcome in Mice J. Immunol., January 1, 2004; 172(1): 240 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pantenburg, F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh T Cells Primed by Leishmania major Infection Cross-React with Alloantigens and Alter the Course of Allograft Rejection J. Immunol., October 1, 2002; 169(7): 3686 - 3693. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sho, A. Yamada, N. Najafian, A. D. Salama, H. Harada, S. E. Sandner, A. Sanchez-Fueyo, X. X. Zheng, T. B. Strom, and M. H. Sayegh Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size J. Immunol., October 1, 2002; 169(7): 3744 - 3751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Coudert, C. Coureau, and J.-C. Guery Preventing NK Cell Activation by Donor Dendritic Cells Enhances Allospecific CD4 T Cell Priming and Promotes Th Type 2 Responses to Transplantation Antigens J. Immunol., September 15, 2002; 169(6): 2979 - 2987. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Boisgerault, Y. Liu, N. Anosova, E. Ehrlich, M. R. Dana, and G. Benichou Role of CD4+ and CD8+ T Cells in Allorecognition: Lessons from Corneal Transplantation J. Immunol., August 15, 2001; 167(4): 1891 - 1899. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yamada, K. Kishimoto, V. M. Dong, M. Sho, A. D. Salama, N. G. Anosova, G. Benichou, D. A. Mandelbrot, A. H. Sharpe, L. A. Turka, et al. CD28-independent Costimulation of T Cells in Alloimmune Responses J. Immunol., July 1, 2001; 167(1): 140 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Heeger, A. Valujskikh, and P. V. Lehmann23 Comprehensive Assessment of Determinant Specificity, Frequency, and Cytokine Signature of the Primed CD8 Cell Repertoire Induced by a Minor Transplantation Antigen J. Immunol., August 1, 2000; 165(3): 1278 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Le Moine, M. Surquin, F. X. Demoor, J. C. Noel, M.-A. Nahori, M. Pretolani, V. Flamand, M. Y. Braun, M. Goldman, and D. Abramowicz IL-5 Mediates Eosinophilic Rejection of MHC Class II-Disparate Skin Allografts in Mice J. Immunol., October 1, 1999; 163(7): 3778 - 3784. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Heeger, N. S. Greenspan, S. Kuhlenschmidt, C. Dejelo, D. E. Hricik, J. A. Schulak, and M. Tary-Lehmann Pretransplant Frequency of Donor-Specific, IFN-{gamma}-Producing Lymphocytes Is a Manifestation of Immunologic Memory and Correlates with the Risk of Posttransplant Rejection Episodes J. Immunol., August 15, 1999; 163(4): 2267 - 2275. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |